We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+19.29%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$16.3B
AUM Growth
+$2.83B
Cap. Flow
-$1.17B
Cap. Flow %
-7.17%
Top 10 Hldgs %
36.28%
Holding
315
New
38
Increased
65
Reduced
120
Closed
39

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$135M
2
NFLX icon
Netflix
NFLX
+$114M
3
CDNS icon
Cadence Design Systems
CDNS
+$90.7M
4
TTD icon
Trade Desk
TTD
+$71.4M
5
AVGO icon
Broadcom
AVGO
+$68.3M

Sector Composition

Rank Sector Weight
1 Technology 38.21%
2 Healthcare 18.58%
3 Financials 14.62%
4 Industrials 12.42%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QGEN icon
126
Qiagen
QGEN
$8.65B
$21.9M 0.13%
415,251
-105,280
-20% -$4.48M
DT icon
127
Dynatrace
DT
$14.8B
$21.8M 0.13%
398,743
-169,169
-30% -$8.55M
DOX icon
128
Amdocs
DOX
$6.41B
$21.8M 0.13%
247,575
+26,431
+12% +$2.2M
CNC icon
129
Centene
CNC
$34.3B
$21.6M 0.13%
290,453
VRDN icon
130
Viridian Therapeutics
VRDN
$2.52B
$21.3M 0.13%
979,917
-620,083
-39% -$9.79M
THC icon
131
Tenet Healthcare
THC
$21.2B
$20.9M 0.13%
276,803
-59,600
-18% -$3.78M
ARQT icon
132
Arcutis Biotherapeutics
ARQT
$3.05B
$20.3M 0.12%
6,297,688
+3,179,744
+102% +$8.64M
RBLX icon
133
Roblox
RBLX
$36.6B
$20.3M 0.12%
444,681
-763,148
-63% -$28.2M
DAWN
134
DELISTED
Day One Biopharmaceuticals
DAWN
$20.2M 0.12%
1,385,000
-550,000
-28% -$6.67M
UNP icon
135
Union Pacific
UNP
$169B
$19.8M 0.12%
80,538
IBKR icon
136
Interactive Brokers
IBKR
$41.1B
$19.7M 0.12%
949,136
+116,168
+14% +$2.38M
IQV icon
137
IQVIA
IQV
$43.1B
$19.7M 0.12%
84,967
-12,494
-13% -$2.57M
FROG icon
138
JFrog
FROG
$10.7B
$19.4M 0.12%
560,916
+32,096
+6% +$868K
BKNG icon
139
Booking.com
BKNG
$132B
$18.8M 0.12%
132,250
WFC icon
140
Wells Fargo
WFC
$268B
$18.6M 0.11%
376,907
+25,186
+7% +$1.09M
MIRM icon
141
Mirum Pharmaceuticals
MIRM
$6.28B
$18.4M 0.11%
625,000
-550,000
-47% -$16.6M
CVE icon
142
Cenovus Energy
CVE
$61.4B
$18.2M 0.11%
923,339
-214,138
-19% -$3.92M
BCYC
143
Bicycle Therapeutics
BCYC
$270M
$18.2M 0.11%
1,004,535
-6,965
-0.7% -$115K
ATR icon
144
AptarGroup
ATR
$7.94B
$18.2M 0.11%
146,908
-6,716
-4% -$844K
FISV
145
Fiserv Inc
FISV
$27.1B
$17.7M 0.11%
132,876
+2,230
+2% +$274K
SE icon
146
Sea Limited
SE
$66.6B
$17.5M 0.11%
432,300
+150,015
+53% +$6.12M
XYZ
147
Block Inc
XYZ
$47.8B
$17.5M 0.11%
+226,096
New +$12.8M
BIO icon
148
Bio-Rad Laboratories Class A
BIO
$9.87B
$17M 0.1%
52,726
+11,151
+27% +$3.5M
BIDU icon
149
Baidu
BIDU
$31.4B
$16.5M 0.1%
138,153
-508,078
-79% -$58.7M
BIOX icon
150
Bioceres Crop Solutions
BIOX
$27.3M
$16.4M 0.1%
1,196,053
+1,009,021
+539% +$11.8M

Similar funds

Polar Capital Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, Polar Capital Holdings held 315 positions worth $16.3B, up 21% from $13.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Polar Capital Holdings withdrew a net $1.17B in Q4 2023, closing 39 positions and reducing 120 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $60.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in Netflix worth $127M.

  • Polar Capital Holdings's largest Q4 2023 buy was Netflix: 2,609,240 shares worth $127M.
  • Polar Capital Holdings added most to Micron Technology in Q4 2023, an estimated $135M increase.
  • Polar Capital Holdings's biggest Q4 2023 reduction was Microsoft, cutting an estimated $164M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q4 2023, selling an estimated $60.5M.
  • Polar Capital Holdings's ten largest holdings make up 36% of its $16.3B portfolio in Q4 2023.
  • Polar Capital Holdings opened 38 new positions and closed 39 in Q4 2023.
  • Polar Capital Holdings's portfolio value rose 21% quarter-over-quarter to $16.3B.

Based on Polar Capital Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.